Following the ouster of CEO Jason Gorevic last year, the telehealth company has been trying to chart a recovery path.
/Quest%20Diagnostics%2C%20Inc_%20inside%20office-by%20Kit%20Leong%20via%20Shutterstock.jpg)
Despite Quest Diagnostics' outperformance relative to its industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
/Agilent%20Technologies%20Inc_%20HQ%20sign-by%20hapabapa%20via%20iStock.jpg)
As Agilent Technologies underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.